Bandaríkin - enska - NLM (National Library of Medicine)

state of florida doh central pharmacy - divalproex sodium (unii: 644vl95ao6) (valproic acid - unii:614oi1z5wi) - valproic acid 500 mg - divalproex sodium is a valproate and is indicated for the treatment of the manic episodes associated with bipolar disorder. a manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, poor judgment, aggressiveness, and possible hostility. the efficacy of divalproex sodium delayed-release tablets, usp was established in 3-week trials with patients meeting dsm-iii-r criteria for bipolar disorder who were hospitalized for acute mania [see clinical studies (14.1) ] . the safety and effectiveness of divalproex sodium delayed-release tablets, usp for long-term use in mania, i.e., more than 3 weeks, has not been demonstrated in controlled clinical trials. therefore, healthcare providers who elect to use divalproex sodium delayed-release tablets, usp for extended periods should continually re-evaluate the long-term usefulness of the drug for

Bandaríkin - enska - NLM (National Library of Medicine)

meda pharmaceuticals - butabarbital sodium (unii: 9wtd50i918) (butabarbital - unii:p0078o25a9) - butabarbital sodium 30 mg - butisol sodium® (butabarbital sodium tablets, usp and butabarbital sodium oral solution, usp) is indicated for use as a sedative or hypnotic. since barbiturates appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks, use of butisol sodium® in treating insomnia should be limited to this time (see clinical pharmacology above). barbiturates are contraindicated in patients with known barbiturate sensitivity. barbiturates are also contraindicated in patients with a history of manifest or latent porphyria. controlled substance: schedule iii. abuse and dependence: abuse and addiction are separate and distinct from physical dependence and tolerance. abuse is characterized by misuse of the drug for non-medical purposes, often in combination with other psychoactive substances. physical dependence is a state of adaptation that is manifested by a specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug and/or ad

Bandaríkin - enska - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 100 mg - extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. extended phenytoin sodium capsules are contraindicated in patients with: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as extended phenytoin sodium capsules, during pregnancy. physicians are advised to recommend that pregnant patients taking extended phenytoin sodium capsules enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. information on the registry can also be found at the website http://www.aedpregnancyregistry.org/ risk summary in humans, prenatal exposure to phenytoin may increase the risks for congenital malformations and other adverse

Bandaríkin - enska - NLM (National Library of Medicine)

marlex pharmaceuticals inc - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 100 mg - extended phenytoin sodium capsules, usp are indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration   and clinical pharmacology   sections). phenytoin, usp is contraindicated in those patients with a history of hypersensitivity to phenytoin, usp, its inactive ingredients, or other hydantoins. coadministration of extended phenytoin sodium is contraindicated with delavirdine due to potential for loss of virologic response and possible resistance to delavirdine or to the class of non-nucleoside reverse transcriptase inhibitors.

Bandaríkin - enska - NLM (National Library of Medicine)

remedyrepack inc. - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 100 mg - extended phenytoin sodium capsules, usp are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. phenytoin is contraindicated in patients with: - a history of hypersensitivity to phenytoin, its inactive ingredients, or other hydantoins [see warnings and precautions (5.5)] . a history of hypersensitivity to phenytoin, its inactive ingredients, or other hydantoins [see warnings and precautions (5.5)] . - a history of prior acute hepatotoxicity attributable to phenytoin [see warnings and precautions (5.6)]. a history of prior acute hepatotoxicity attributable to phenytoin [see warnings and precautions (5.6)]. - co-administration with delavirdine because of the potential for loss of virologic response and possible resistance to delavirdine or to the class of non-nucleoside reverse transcriptase inhibitors. co-administration with delavirdine because of the potential for loss of vir

Bandaríkin - enska - NLM (National Library of Medicine)

state of florida doh central pharmacy - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 100 mg - extended phenytoin sodium capsules, usp are indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration and clinical pharmacology sections). phenytoin is contraindicated in those patients who are hypersensitive to phenytoin or other hydantoins.

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - sodium valproate - tablet - 100mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - sodium valproate - gastro-resistant tablet - 200mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - sodium valproate - gastro-resistant tablet - 200mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - sodium valproate - gastro-resistant tablet - 200mg